SCHEMBL528195

SCHEMBL528195

CCC(=O)NCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078660 0.97 MEN1 (0.50)
Benzene SCHEMBL28030653 0.95 FAAH (0.48)
SCHEMBL23471380 0.95 MEN1 (0.48)
SCHEMBL28450124 0.87 FAAH (0.43)
SCHEMBL1767620 0.82 FAAH (0.43)
Toluene SCHEMBL27866094 0.82 ITGB3 (0.47)
SCHEMBL2807522 0.79 EGLN1 (0.46)
SCHEMBL233413 0.79 FAAH (0.55)
SCHEMBL31023073 0.79 FAAH (0.49)
SCHEMBL2651423 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240316165-A1 POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA ARES CAPITAL CORPORATION, AS AGENT 2024-09-26 US claimed
US-20240293476-A1 Methods and Compositions for Changing Metabolite Levels in a Subject ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-09-05 US claimed
EP-4386090-A1 METHOD FOR DETERMINING AND IMPROVING THE POTENTIAL EFFICACY OF ANTICANCER TREATMENT ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) 2024-06-19 EP claimed
US-11906510-B2 Metabolic profiling by reverse-phase/ion-exchange mass spectrometry STANFORD JUNIOR UNIVERSITY (US) 2024-02-20 US claimed
WO-2023230560-A1 TREATMENT OF ORGANIC ACIDEMIAS OR PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION WITH MODULATORS OF PANTOTHENATE KINASES COA THERAPEUTICS, INC. (US) 2023-11-30 WO claimed
WO-2023287751-A1 POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA MODERNATX, INC. (US) 2023-01-19 WO claimed
WO-2022190030-A1 A TOPICAL FORMULATION FOR THE TREATMENT OF SKIN DISEASES AVACA PHARMA PRIVATE LIMITED (IN) 2022-09-15 WO claimed
EP-3908374-A1 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES Epitracker, Inc. (US) 2021-11-17 EP claimed
US-20210330734-A1 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES Epitracker, Inc. 2021-10-28 US claimed
CN-113325110-A Method for determining specific organic acid by tandem mass spectrometry 浙江大学 2021-08-31 CN claimed
US-20050171194-A1 Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions YU RUEY J (US) 2005-08-04 US claimed
WO-2005055947-A2 ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS YU RUEY J (US) 2005-06-23 WO claimed
EP-0845505-B1 Spherical colour pigments, process for their preparation and their use DMC2 DEGUSSA METALS CATALYSTS (DE) 2001-10-04 EP claimed
EP-1098630-A2 COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION Biomed Research and Technologies, Inc. (US) 2001-05-16 EP claimed
US-6149924-A FOR TOPICAL APPLICATION BIOMED RESEARCH & TECHNOLOGIES, INC. (US) 2000-11-21 US claimed
WO-2000004870-A2 COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION BIOMED RESEARCH AND TECHNOLOGIES, INC. (US) 2000-02-03 WO claimed
US-4874752-A INHIBIT COLLAGEN BIOSYNTHESIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-10-17 US claimed
US-4766133-A ANTIULCER AGENTS HOFFMAN-LA ROCHE INC. (US) 1988-08-23 US claimed
EP-0273188-A1 Process for preparing therapeutically active derivatives of ursodeoxycholic acid. Jago Research AG (CH) 1988-07-06 EP claimed
EP-0214479-A2 Benzimidazol-2-ylpyridinium compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-03-18 EP claimed